Burim Regislaine Valéria, Canalle Renata, Martinelli Ana de Lôurdes Candolo, Takahashi Catarina Satie
Department of Genetics and. Department of Internal Medicine, Faculty of Medicine of Ribeirão Preto, São Paulo University, Av. Bandeirantes 3900, 14049-900 Ribeirão Preto, São Paulo, Brazil.
Mutagenesis. 2004 Jul;19(4):291-8. doi: 10.1093/mutage/geh034.
Excessive alcohol consumption may cause the development of pathologies in the liver and pancreas and various digestive tract cancers. The enzymes GSTM1, GSTT1, GSTP1, CYP1A1 and CYP2E1 are involved in the bioactivation and detoxification of a variety of xenobiotics present in food, organic solvents, tobacco smoke, drugs, pesticides, environmental pollutants and alcoholic drinks. Polymorphisms in the genes coding for these enzymes have been associated with susceptibility to different diseases, including ethanol-related diseases. To investigate whether these polymorphisms represent risk-modifying factors for ethanol-related diseases, a study was conducted involving 120 Brazilian alcoholics and 221 controls with similar ethnic backgrounds. The distribution of alcoholics groups was as follows: 65 with liver cirrhosis, 14 with chronic pancreatitis and 41 without cirrhosis or pancreatitis. The data revealed that carriers of the rare GSTP1 Val allele were at higher risk of liver cirrhosis and pancreatitis, since we found higher frequencies of the Val/Val genotype in alcoholics with liver cirrhosis (15.4%) and pancreatitis (28.6%) in comparison with alcoholics without disease (7.3%). No differences were found in the prevalences of the GSTM1 and GSTT1 null genotypes between alcoholics and the controls and no association was found between the rare CYP2E1 c2 allele and liver cirrhosis and pancreatitis. However, when the mutant CYP1A1 allele was compared between alcoholics and controls, the m2/m2 genotype was more prevalent in the liver cirrhosis alcoholics (7.7%) than in the controls (1.4%) and this difference was statistically significant (P = 0.03, OR = 5.33). In conclusion, our data indicate an association between occurrence of the Val/Val GSTP1 genotype and chronic pancreatitis and an association between the m2/m2 CYP1A1 genotype and alcoholic liver cirrhosis. This could indicate that persons with these genotypes are genetically more prone to the development of alcoholic pancreatitis and alcoholic cirrhosis, respectively.
过量饮酒可能导致肝脏和胰腺出现病变以及引发各种消化道癌症。GSTM1、GSTT1、GSTP1、CYP1A1和CYP2E1酶参与食物、有机溶剂、烟草烟雾、药物、农药、环境污染物和酒精饮料中多种外源性物质的生物活化和解毒过程。编码这些酶的基因多态性与包括乙醇相关疾病在内的不同疾病易感性有关。为了研究这些多态性是否代表乙醇相关疾病的风险修饰因素,开展了一项研究,涉及120名巴西酗酒者和221名具有相似种族背景的对照者。酗酒者分组情况如下:65例肝硬化患者,14例慢性胰腺炎患者,41例无肝硬化或胰腺炎患者。数据显示,罕见的GSTP1 Val等位基因携带者患肝硬化和胰腺炎的风险更高,因为我们发现肝硬化酗酒者(15.4%)和胰腺炎酗酒者(28.6%)中Val/Val基因型的频率高于无病酗酒者(7.3%)。酗酒者和对照者之间GSTM1和GSTT1无效基因型的患病率没有差异,并且罕见的CYP2E1 c2等位基因与肝硬化和胰腺炎之间没有关联。然而,当比较酗酒者和对照者之间的突变CYP1A1等位基因时,m2/m2基因型在肝硬化酗酒者(7.7%)中比在对照者(1.4%)中更普遍,且这种差异具有统计学意义(P = 0.03,OR = 5.33)。总之,我们的数据表明Val/Val GSTP1基因型的出现与慢性胰腺炎之间存在关联,m2/m2 CYP1A1基因型与酒精性肝硬化之间存在关联。这可能表明具有这些基因型的人分别在遗传上更容易患酒精性胰腺炎和酒精性肝硬化。